Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

P L Ventures Bioadvance


  • Large Shareholder at Nupathe Inc. (PATH), 2012-10-17
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PATH $3.39 37,593 Large Shareholder 268,879 2012-10-17 Filing
PATH $3.29 72,407 Large Shareholder 306,472 2012-10-16 Filing
PATH $3.37 113,000 Large Shareholder 378,879 2012-10-15 Filing